Charles Schwab’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Buy |
19,049
+42
| +0.2% | +$381 | ﹤0.01% | 3389 |
|
|
2025
Q1 | $181K | Buy |
19,007
+2,552
| +16% | +$24.3K | ﹤0.01% | 3274 |
|
|
2024
Q4 | $185K | Hold |
16,455
| – | – | ﹤0.01% | 3338 |
|
|
2024
Q3 | $236K | Sell |
16,455
-1,999
| -11% | -$28.7K | ﹤0.01% | 3314 |
|
|
2024
Q2 | $319K | Buy |
+18,454
| New | +$319K | ﹤0.01% | 3354 |
|
|
2022
Q2 | – | Sell |
-10,191
| Closed | -$200K | – | 3579 |
|
|
2022
Q1 | $200K | Buy |
10,191
+372
| +4% | +$7.3K | ﹤0.01% | 3306 |
|
|
2021
Q4 | $239K | Hold |
9,819
| – | – | ﹤0.01% | 3332 |
|
|
2021
Q3 | $384K | Hold |
9,819
| – | – | ﹤0.01% | 3213 |
|
|
2021
Q2 | $442K | Buy |
+9,819
| New | +$442K | ﹤0.01% | 3193 |
|